MiR-506 suppresses proliferation of hepatoma cells lhrough targeting YAP mRNA 3＇UTR

• Published in: 中国药理学报：英文版 no. 9; pp. 1207 - 1214
• Main Author: Yue WANG Ming CUI Bao-di SUN Fa-bao LIU Xiao-dong ZHANG Li-hong YE
• Format: Journal Article
• Language: English
• Published: 2014
• Subjects: HepG2; P基因; RT-PCR检测; Western印迹; 细胞增殖; 结缔组织生长因子; 肝癌细胞; 荧光素酶报告基因
• ISSN: 1671-4083; 1745-7254

Aim： MiR-506 is a miRNA involved in carcinogenesis of several kinds of cancer. In this study, we explored whether miR-506 played a critical role in hepatocellular carcinoma （HCC）. Methods： Twenty HCC and adjacent normal liver tissue samples were collected. Human hepatoma cell lines HepG2 and H7402 were used for in vitro studies. The expression of miR-506 and transcriptional co-activator YAP was examined using qRT-PCR. Western blot analysis was used to measure the expression of YAP and its target genes. Luciferase reporter gene assay was used to identify YAP as a target gene of miR-506. MTT and EdU assays were carried out for functional analysis. Results： The expression of miR-506 was significantly lower in HCC than in adjacent normal liver tissues. Bioinformatics analysis revealed that YAP mRNA might be one of the targets of miR-506, and miR-506 in HCC tissues was found to be negatively correlated with YAP （r=-0.605）. In both HepG2 and H7402 cells, miR-506 dose-dependently down-regulated YAP and its target genes c-Myc and the connective tissue growth factor （CTGF）. Luciferase reporter gene assays demonstrated that miR-506 targeted the wild type 3＇UTR of YAP mRNA, but not a 3＇UTR with a mutant seed site. Furthermore, miR-506 significantly inhibited the proliferation of HepG2 and H7402 cells, while anti-miR-506 enhanced the cell proliferation, which was blocked by YAP siRNA. Conclusion： MiR-506 suppresses the proliferation of hepatoma cells by targeting YAP mRNA.